{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:09:45Z","timestamp":1784743785202,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13124-w","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:05:50Z","timestamp":1776092750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and risk factors associated with asymptomatic bacteriuria in diabetic postmenopausal women in Tripoli, Libya"],"prefix":"10.1186","volume":"26","author":[{"given":"Abir Ben","family":"Ashur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Gashout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Abou-Aisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer M.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Refaat M.","family":"Gabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"10440","key":"13124_CR1","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/S0140-6736(24)00769-4","volume":"403","author":"CJL Murray","year":"2024","unstructured":"Murray CJL. GBD 2021 Collaborators. Findings from the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2259\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(24)00769-4.","journal-title":"Lancet"},{"key":"13124_CR2","unstructured":"Magliano DJ, Boyko EJ. IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS [Internet]. 10th edition. Brussels: international diabetes federation; 2021. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK581934\/."},{"key":"13124_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/DMSO.S51792","volume":"8","author":"O Nitzan","year":"2015","unstructured":"Nitzan O, Elias M, Chazan B, Saliba W. Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes Metab Syndr Obes. 2015;8:129\u201336. https:\/\/doi.org\/10.2147\/DMSO.S51792. Published 2015 Feb 26.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"13124_CR4","doi-asserted-by":"publisher","unstructured":"Jha R, Lopez-Trevino S, Kankanamalage HR, Jha JC. Diabetes and renal complications: an overview on pathophysiology, biomarkers and therapeutic interventions. Biomedicines. 2024;12(5):1098. Published 2024 May 15. https:\/\/doi.org\/10.3390\/biomedicines12051098.","DOI":"10.3390\/biomedicines12051098"},{"issue":"8","key":"13124_CR5","doi-asserted-by":"publisher","first-page":"e5464","DOI":"10.7759\/cureus.5464","volume":"11","author":"R Kumar","year":"2019","unstructured":"Kumar R, Kumar R, Perswani P, Taimur M, Shah A, Shaukat F. Clinical and Microbiological Profile of Urinary Tract Infections in Diabetic versus Non-Diabetic Individuals. Cureus. 2019;11(8):e5464. https:\/\/doi.org\/10.7759\/cureus.5464. Published 2019 Aug 22.","journal-title":"Cureus"},{"issue":"10","key":"13124_CR6","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1093\/cid\/ciy1121","volume":"68","author":"LE Nicolle","year":"2019","unstructured":"Nicolle LE, Gupta K, Bradley SF, et al. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2019;68(10):e83\u2013110. https:\/\/doi.org\/10.1093\/cid\/ciy1121.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"13124_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.4103\/jfmpc.jfmpc_403_18","volume":"8","author":"A Bharti","year":"2019","unstructured":"Bharti A, Chawla SPS, Kumar S, et al. Asymptomatic bacteriuria among the patients of type 2 diabetes mellitus. J Family Med Prim Care. 2019;8(2):539\u201343. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_403_18.","journal-title":"J Family Med Prim Care"},{"issue":"10","key":"13124_CR8","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1093\/cid\/ciy1121","volume":"68","author":"LE Nicolle","year":"2019","unstructured":"8.Nicolle LE, Gupta K, Bradley SF, et al. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2019;68(10):e83\u2013110. https:\/\/doi.org\/10.1093\/cid\/ciy1121.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"13124_CR9","doi-asserted-by":"publisher","first-page":"722","DOI":"10.2337\/diacare.23.6.722","volume":"23","author":"LE Nicolle","year":"2000","unstructured":"Nicolle LE. Asymptomatic bacteriuria in diabetic women. Diabetes Care. 2000;23(6):722\u20133. https:\/\/doi.org\/10.2337\/diacare.23.6.722.","journal-title":"Diabetes Care"},{"issue":"1","key":"13124_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2337\/dc10-0421","volume":"34","author":"M Renko","year":"2011","unstructured":"Renko M, Tapanainen P, Tossavainen P, Pokka T, Uhari M. Meta-analysis of the significance of asymptomatic bacteriuria in diabetes. Diabetes Care. 2011;34(1):230\u20135. https:\/\/doi.org\/10.2337\/dc10-0421.","journal-title":"Diabetes Care"},{"issue":"6","key":"13124_CR11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/aje\/kwi078","volume":"161","author":"EJ Boyko","year":"2005","unstructured":"Boyko EJ, Fihn SD, Scholes D, Abraham L, Monsey B. Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women. Am J Epidemiol. 2005;161(6):557\u201364. https:\/\/doi.org\/10.1093\/aje\/kwi078.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"13124_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11908-999-0043-1","volume":"1","author":"B Foxman","year":"1999","unstructured":"Foxman B. Urinary Tract Infection in Postmenopausal Women. Curr Infect Dis Rep. 1999;1(4):367\u201370. https:\/\/doi.org\/10.1007\/s11908-999-0043-1.","journal-title":"Curr Infect Dis Rep"},{"key":"13124_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12879-021-06106-7","volume":"21","author":"AH Aamir","year":"2021","unstructured":"Aamir AH, Raja UY, Asghar A, et al. Asymptomatic urinary tract infections and associated risk factors in Pakistani Muslim type 2 diabetic patients. BMC Infect Dis. 2021;21:388. https:\/\/doi.org\/10.1186\/s12879-021-06106-7.","journal-title":"BMC Infect Dis"},{"key":"13124_CR14","unstructured":"Ben Ashur A, Gashout A, Abou-Aisha K, Salem A, Gabre R. Participant questionnaire for ASB study (English Version). 2026."},{"issue":"3","key":"13124_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.5173\/ceju.2013.03.art17","volume":"66","author":"G Kasyan","year":"2013","unstructured":"Kasyan G, Berketova TY, Rogozin AK, Pushkar DY. Asymptomatic bacteriuria in postmenopausal women with diabetes mellitus. Cent Eur J Urol. 2013;66(3):320\u20136. https:\/\/doi.org\/10.5173\/ceju.2013.03.art17.","journal-title":"Cent Eur J Urol"},{"issue":"8","key":"13124_CR16","doi-asserted-by":"publisher","first-page":"e236","DOI":"10.1016\/j.amjmed.2022.03.015","volume":"135","author":"T Luu","year":"2022","unstructured":"Luu T, Albarillo FS. Asymptomatic Bacteriuria: Prevalence, Diagnosis, Management, and Current Antimicrobial Stewardship Implementations. Am J Med. 2022;135(8):e236\u201344. https:\/\/doi.org\/10.1016\/j.amjmed.2022.03.015.","journal-title":"Am J Med"},{"issue":"1","key":"13124_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12877-019-1181-4","volume":"19","author":"M Biggel","year":"2019","unstructured":"Biggel M, Heytens S, Latour K, Bruyndonckx R, Goossens H, Moons P. Asymptomatic bacteriuria in older adults: the most fragile women are prone to long-term colonization. BMC Geriatr. 2019;19(1):170. https:\/\/doi.org\/10.1186\/s12877-019-1181-4. Published 2019 Jun 21.","journal-title":"BMC Geriatr"},{"issue":"12","key":"13124_CR18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.4111\/kju.2011.52.12.801","volume":"52","author":"R Raz","year":"2011","unstructured":"Raz R. Urinary tract infection in postmenopausal women. Korean J Urol. 2011;52(12):801\u20138. https:\/\/doi.org\/10.4111\/kju.2011.52.12.801.","journal-title":"Korean J Urol"},{"issue":"2","key":"13124_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12020-023-03469-6","volume":"82","author":"M Dai","year":"2023","unstructured":"Dai M, Hua S, Yang J, et al. Incidence and risk factors of asymptomatic bacteriuria in patients with type 2 diabetes mellitus: a meta-analysis. Endocrine. 2023;82(2):263\u201381. https:\/\/doi.org\/10.1007\/s12020-023-03469-6.","journal-title":"Endocrine"},{"issue":"6","key":"13124_CR20","doi-asserted-by":"publisher","first-page":"744","DOI":"10.2337\/diacare.23.6.744","volume":"23","author":"SE Geerlings","year":"2000","unstructured":"Geerlings SE, Stolk RP, Camps MJ, et al. Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care. 2000;23(6):744\u20139. https:\/\/doi.org\/10.2337\/diacare.23.6.744.","journal-title":"Diabetes Care"},{"issue":"5","key":"13124_CR21","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2174\/1573399815666191024085838","volume":"16","author":"A Berbudi","year":"2020","unstructured":"Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 Diabetes and its Impact on the Immune System. Curr Diabetes Rev. 2020;16(5):442\u20139. https:\/\/doi.org\/10.2174\/1573399815666191024085838.","journal-title":"Curr Diabetes Rev"},{"key":"13124_CR22","unstructured":"Zhou K, Lansang MC, et al. Diabetes mellitus and infection. In: Feingold KR, Ahmed SF, Anawalt B, eds. Endotext. South Dartmouth (MA): MDText.com, Inc., 2024."},{"issue":"5","key":"13124_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269\u201384. https:\/\/doi.org\/10.1038\/nrmicro3432.","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"13124_CR24","doi-asserted-by":"publisher","first-page":"e9069","DOI":"10.7759\/cureus.9069","volume":"12","author":"SMJ Zaidi","year":"2020","unstructured":"Zaidi SMJ, Kaneez M, Almas T, et al. Gauging the Risk Factors for Asymptomatic Bacteriuria in Type-2 Diabetic Women: A Case-Control Study. Cureus. 2020;12(7):e9069. https:\/\/doi.org\/10.7759\/cureus.9069. Published 2020 Jul 8.","journal-title":"Cureus"},{"key":"13124_CR25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2334-6-54","volume":"6","author":"M Bonadio","year":"2006","unstructured":"Bonadio M, Costarelli S, Morelli G, Tartaglia T. The influence of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in elderly adult patients with urinary tract infection. BMC Infect Dis. 2006;6:54. https:\/\/doi.org\/10.1186\/1471-2334-6-54. Published 2006 Mar 17.","journal-title":"BMC Infect Dis"},{"key":"13124_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/0-306-46840-9_41","volume":"485","author":"SE Geerlings","year":"2000","unstructured":"Geerlings SE, Stolk RP, Camps MJ, et al. Asymptomatic bacteriuria can be considered a diabetic complication in women with diabetes mellitus. Adv Exp Med Biol. 2000;485:309\u201314. https:\/\/doi.org\/10.1007\/0-306-46840-9_41.","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"13124_CR27","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3855\/jidc.7426","volume":"10","author":"N Mathlouthi","year":"2016","unstructured":"Mathlouthi N, Al-Bayssari C, El Salabi A, et al. Carbapenemases and extended-spectrum \u03b2-lactamases producing Enterobacteriaceae isolated from Tunisian and Libyan hospitals. J Infect Dev Ctries. 2016;10(7):718\u201327. https:\/\/doi.org\/10.3855\/jidc.7426. Published 2016 Aug 2.","journal-title":"J Infect Dev Ctries"},{"issue":"3","key":"13124_CR28","doi-asserted-by":"publisher","first-page":"504","DOI":"10.21608\/jbaar.2024.304756.1056","volume":"10","author":"E Al-Layla","year":"2024","unstructured":"Al-Layla E, AlTaie A, Haddad M, Abdullah B, Saadi A. molecular detection of asymptomatic bacteriuria and its bacteriophage from adolescents in Mosul City \/ Iraq. J Bioscience Appl Res. 2024;10(3):504\u201317. https:\/\/doi.org\/10.21608\/jbaar.2024.304756.1056.","journal-title":"J Bioscience Appl Res"},{"issue":"1","key":"13124_CR29","first-page":"e02","volume":"9","author":"KY Abujheisha","year":"2019","unstructured":"Abujheisha KY. Asymptomatic bacteriuria in type II diabetics and non diabetics: Risk factors, bacterial types and their corresponding resistance pattern. J Ren Injury Prev. 2019;9(1):e02.","journal-title":"J Ren Injury Prev"},{"issue":"6","key":"13124_CR30","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/s0924-8579(02)00090-0","volume":"19","author":"SE Geerlings","year":"2002","unstructured":"Geerlings SE, Meiland R, Hoepelman AI. Pathogenesis of bacteriuria in women with diabetes mellitus. Int J Antimicrob Agents. 2002;19(6):539\u201345. https:\/\/doi.org\/10.1016\/s0924-8579(02)00090-0.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"13124_CR31","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1086\/381755","volume":"38","author":"M Bonadio","year":"2004","unstructured":"Bonadio M, Boldrini E, Forotti G, et al. Asymptomatic bacteriuria in women with diabetes: influence of metabolic control. Clin Infect Dis. 2004;38(6):e41\u20135. https:\/\/doi.org\/10.1086\/381755.","journal-title":"Clin Infect Dis"},{"issue":"3\u20134","key":"13124_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","volume":"26","author":"SE Geerlings","year":"1999","unstructured":"Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26(3\u20134):259\u201365. https:\/\/doi.org\/10.1111\/j.1574-695X.1999.tb01397.x.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"13124_CR33","doi-asserted-by":"publisher","first-page":"e13562","DOI":"10.7759\/cureus.13562","volume":"13","author":"MS Asghar","year":"2021","unstructured":"Asghar MS, Akram M, Singh M, et al. Characteristics of Asymptomatic Bacteriuria in Diabetes Mellitus Patients: A Retrospective Observational Study. Cureus. 2021;13(2):e13562. https:\/\/doi.org\/10.7759\/cureus.13562. Published 2021 Feb 26.","journal-title":"Cureus"},{"issue":"3","key":"13124_CR34","doi-asserted-by":"publisher","first-page":"300060524123351","DOI":"10.1177\/03000605241233515","volume":"52","author":"AO Ibrahim","year":"2024","unstructured":"Ibrahim AO, Bello IS, Ajetunmobi OA, et al. Asymptomatic bacteriuria in patients with type 2 diabetes mellitus in rural southwestern Nigeria: a cross-sectional study. J Int Med Res. 2024;52(3):3000605241233515. https:\/\/doi.org\/10.1177\/03000605241233515.","journal-title":"J Int Med Res"},{"issue":"1","key":"13124_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12938-025-01415-3","volume":"24","author":"F Lin","year":"2025","unstructured":"Lin F, Ma L, Sheng Z. Health disorders in menopausal women: microbiome alterations, associated problems, and possible treatments. Biomed Eng Online. 2025;24(1):84. https:\/\/doi.org\/10.1186\/s12938-025-01415-3. Published 2025 Jul 7.","journal-title":"Biomed Eng Online"},{"issue":"3","key":"13124_CR36","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.mayocp.2020.07.033","volume":"96","author":"P Pataky","year":"2021","unstructured":"Pataky P MW, Young WF, Nair KS. Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications. Mayo Clin Proc. 2021;96(3):788\u2013814. https:\/\/doi.org\/10.1016\/j.mayocp.2020.07.033.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"13124_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1210\/er.2016-1146","volume":"38","author":"F Mauvais-Jarvis","year":"2017","unstructured":"Mauvais-Jarvis F, Manson JE, Stevenson JC, Fonseca VA. Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications. Endocr Rev. 2017;38(3):173\u201388. https:\/\/doi.org\/10.1210\/er.2016-1146.","journal-title":"Endocr Rev"},{"issue":"1","key":"13124_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00192-020-04397-z","volume":"32","author":"YY Chen","year":"2021","unstructured":"Chen YY, Su TH, Lau HH. Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials. Int Urogynecol J. 2021;32(1):17\u201325. https:\/\/doi.org\/10.1007\/s00192-020-04397-z.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"13124_CR39","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/clinids\/12.5.150","volume":"13","author":"GG Zhanel","year":"1991","unstructured":"Zhanel GG, Harding GK, Nicolle LE. Asymptomatic bacteriuria in patients with diabetes mellitus. Rev Infect Dis. 1991;13(1):150\u20134. https:\/\/doi.org\/10.1093\/clinids\/12.5.150.","journal-title":"Rev Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13124-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13124-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13124-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T06:44:47Z","timestamp":1776321887000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13124-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13124"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13124-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"28 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This cross-sectional study obtained formal ethical approval from the Institutional Review Board (IRB) of the Medical Affairs Directorate of the Department of Endocrinology and Diabetes, Tripoli University Hospital (Approval Reference Number: 31447). The name of the approving body provided here is the formal English translation of the official name appearing on the institutional Arabic stamp of the ethical approval certificate. The procedures and protocols used in this study relating to human subjects were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. The requirement for informed consent was formally waived by the Institutional Review Board (IRB) of the Medical Affairs Directorate of the Department of Endocrinology and Diabetes, Tripoli University Hospital (the official name of the approving body as it appears on the institutional stamp). The official approval letter for this research protocol (Ref: 31447) explicitly states: \u201cThere is no need for informed consent.\u201d This waiver was granted on the basis that the study was observational, posed minimal risk to participants, and all data were gathered and analyzed anonymously using the secure electronic database to ensure patient confidentiality. The questionnaire used for data collection was developed specifically for this study. It was administered in the local language by trained data collectors, and an English language version has been provided as Supplementary File 1 and is cited accordingly in the Methods section of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"768"}}